Se-Methyl-Seleno-L-Cysteine or Selenomethionine in Preventing Prostate Cancer in Healthy Participants

NCT01497431 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

66

Enrollment

NIH

Sponsor class

Conditions

No Evidence of Disease
Prostate Carcinoma

Interventions

DIETARY_SUPPLEMENT: Selenium
OTHER: Placebo
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study
DRUG: Methylselenocysteine

Sponsor

National Cancer Institute (NCI)